INS and Ovarian Hyperandrogenism: We tentatively suggest that insulin’s stimulatory effect on ovarian androgen synthesis may lead to the development of ovarian hyperandrogenism in susceptible women [49], which in turn may reduce breast cancer risk in premenopausal women by causing chronic anovulation with reduced ovarian production of estradiol and progesterone [50].